Ironwood Investment Counsel LLC raised its position in Colgate-Palmolive Company (NYSE:CL) by 0.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 10,317 shares of the company’s stock after buying an additional 2 shares during the quarter. Ironwood Investment Counsel LLC’s holdings in Colgate-Palmolive were worth $765,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also recently modified their holdings of CL. Blue Chip Partners Inc. lifted its position in shares of Colgate-Palmolive by 0.4% in the second quarter. Blue Chip Partners Inc. now owns 1,813 shares of the company’s stock valued at $134,000 after acquiring an additional 8 shares in the last quarter. Cue Financial Group Inc. lifted its position in Colgate-Palmolive by 0.3% during the second quarter. Cue Financial Group Inc. now owns 4,854 shares of the company’s stock worth $360,000 after buying an additional 14 shares during the period. Cornerstone Financial Partners LLC lifted its position in Colgate-Palmolive by 0.5% during the second quarter. Cornerstone Financial Partners LLC now owns 3,813 shares of the company’s stock worth $282,000 after buying an additional 19 shares during the period. M Holdings Securities Inc. lifted its position in Colgate-Palmolive by 0.4% during the first quarter. M Holdings Securities Inc. now owns 5,366 shares of the company’s stock worth $393,000 after buying an additional 21 shares during the period. Finally, AlphaMark Advisors LLC lifted its position in Colgate-Palmolive by 1.5% during the second quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock worth $126,000 after buying an additional 25 shares during the period. Institutional investors own 73.46% of the company’s stock.
Several equities research analysts have commented on the company. Citigroup Inc. dropped their price target on Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating for the company in a research note on Thursday, November 2nd. Zacks Investment Research upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $81.00 price objective for the company in a research note on Monday, October 23rd. KeyCorp restated a “hold” rating on shares of Colgate-Palmolive in a research note on Monday, October 16th. SunTrust Banks, Inc. upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating and raised their price objective for the company from $65.00 to $85.00 in a research note on Wednesday, October 11th. Finally, Jefferies Group LLC restated a “hold” rating and set a $79.00 price objective on shares of Colgate-Palmolive in a research note on Thursday, September 28th. One investment analyst has rated the stock with a sell rating, fifteen have assigned a hold rating and four have assigned a buy rating to the stock. Colgate-Palmolive has an average rating of “Hold” and an average target price of $76.67.
In other news, Director Stephen I. Sadove sold 20,780 shares of the business’s stock in a transaction that occurred on Monday, November 6th. The stock was sold at an average price of $70.52, for a total value of $1,465,405.60. Following the transaction, the director now directly owns 36,268 shares of the company’s stock, valued at approximately $2,557,619.36. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Victoria L. Dolan sold 10,000 shares of the business’s stock in a transaction that occurred on Thursday, November 9th. The stock was sold at an average price of $73.07, for a total value of $730,700.00. Following the completion of the transaction, the insider now directly owns 60,528 shares in the company, valued at $4,422,780.96. The disclosure for this sale can be found here. Insiders have sold 173,673 shares of company stock worth $12,629,293 over the last 90 days. Corporate insiders own 1.02% of the company’s stock.
Colgate-Palmolive Company (NYSE CL) opened at $72.01 on Monday. The company has a debt-to-equity ratio of 24.42, a current ratio of 1.23 and a quick ratio of 0.92. The company has a market capitalization of $63,232.34, a PE ratio of 25.09, a PEG ratio of 3.30 and a beta of 0.80. Colgate-Palmolive Company has a 12 month low of $63.43 and a 12 month high of $77.27.
Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, October 27th. The company reported $0.73 EPS for the quarter, hitting analysts’ consensus estimates of $0.73. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. The business had revenue of $3.97 billion for the quarter, compared to analyst estimates of $3.94 billion. During the same period in the previous year, the company posted $0.73 earnings per share. The firm’s revenue for the quarter was up 2.8% on a year-over-year basis. research analysts predict that Colgate-Palmolive Company will post 2.88 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which was paid on Wednesday, November 15th. Investors of record on Monday, October 23rd were paid a dividend of $0.40 per share. The ex-dividend date of this dividend was Friday, October 20th. This represents a $1.60 annualized dividend and a yield of 2.22%. Colgate-Palmolive’s dividend payout ratio is 61.78%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.